Kezar Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018
Market Capitalization	46	69	481	822	242	77	Upgrade
Market Cap Growth	-70.38%	-85.69%	-41.42%	240.23%	214.65%	-82.98%	Upgrade
Enterprise Value	-116	-114	226	627	107	5	Upgrade
PE Ratio	-	-0.68	-7.05	-15.04	-5.79	-2.19	Upgrade
PS Ratio	6.55	9.84	-	-	-	-	Upgrade
PB Ratio	0.27	0.37	1.78	4.17	1.71	0.98	Upgrade
P/FCF Ratio	-0.77	-0.83	-7.97	-19.22	-6.50	-2.52	Upgrade
P/OCF Ratio	-0.78	-0.84	-8.18	-19.36	-6.54	-2.57	Upgrade
EV/Sales Ratio	-13.70	-16.22	-	-	-	-	Upgrade
EV/EBITDA Ratio	0.97	1.14	-3.42	-11.85	-2.65	-0.15	Upgrade
EV/EBIT Ratio	0.96	1.13	-3.37	-11.52	-2.55	-0.14	Upgrade
EV/FCF Ratio	1.13	1.36	-3.74	-14.68	-2.87	-0.16	Upgrade
Debt / Equity Ratio	0.11	0.10	0.08	0.07	0.04	0.08	Upgrade
Debt / EBITDA Ratio	-0.19	-0.19	-0.32	-0.27	-0.14	-0.19	Upgrade
Debt / FCF Ratio	-0.21	-0.23	-0.35	-0.33	-0.15	-0.21	Upgrade
Quick Ratio	11.13	11.35	25.15	25.37	21.80	13.03	Upgrade
Current Ratio	11.49	11.66	25.98	25.77	22.48	13.52	Upgrade
Asset Turnover	0.03	0.03	0	0	0	0	Upgrade
Interest Coverage	-63.13	-64.72	-56.59	-342.58	-	-	Upgrade
Return on Equity (ROE)	-50.40%	-45.90%	-25.20%	-37.20%	-29.20%	-38.80%	Upgrade
Return on Assets (ROA)	-43.40%	-40.00%	-23.30%	-34.10%	-27.10%	-34.60%	Upgrade
Return on Capital (ROIC)	-59.02%	-53.96%	-24.44%	-25.91%	-29.33%	-44.24%	Upgrade
Earnings Yield	-220.89%	-147.92%	-14.18%	-6.65%	-17.28%	-45.71%	Upgrade
FCF Yield	-185.64%	-121.17%	-12.55%	-5.20%	-15.38%	-39.71%	Upgrade
Buyback Yield / Dilution	-0.65%	-7.70%	-27.69%	-19.90%	-130.58%	-85.92%	Upgrade
Total Shareholder Return	-0.65%	-7.70%	-27.69%	-19.90%	-130.58%	-85.92%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).